S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
His system isolated NVIDIA - Here's His Next Buy. (Ad)
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
His system isolated NVIDIA - Here's His Next Buy. (Ad)
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
Canadian autoworkers ratify new labor agreement with Ford
His system isolated NVIDIA - Here's His Next Buy. (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
A coal mine fire in southern China's Guizhou province kills 16 people
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
His system isolated NVIDIA - Here's His Next Buy. (Ad)
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
His system isolated NVIDIA - Here's His Next Buy. (Ad)
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
Canadian autoworkers ratify new labor agreement with Ford
His system isolated NVIDIA - Here's His Next Buy. (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
A coal mine fire in southern China's Guizhou province kills 16 people
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
His system isolated NVIDIA - Here's His Next Buy. (Ad)
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
His system isolated NVIDIA - Here's His Next Buy. (Ad)
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
Canadian autoworkers ratify new labor agreement with Ford
His system isolated NVIDIA - Here's His Next Buy. (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
A coal mine fire in southern China's Guizhou province kills 16 people
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
His system isolated NVIDIA - Here's His Next Buy. (Ad)
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
His system isolated NVIDIA - Here's His Next Buy. (Ad)
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
Canadian autoworkers ratify new labor agreement with Ford
His system isolated NVIDIA - Here's His Next Buy. (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
A coal mine fire in southern China's Guizhou province kills 16 people
NASDAQ:CMPX

Compass Therapeutics (CMPX) News Today

$1.96
+0.09 (+4.81%)
(As of 09/22/2023 ET)
Compare
Today's Range
$1.86
$1.98
50-Day Range
$1.87
$2.93
52-Week Range
$1.81
$5.65
Volume
340,830 shs
Average Volume
185,588 shs
Market Capitalization
$249.82 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$9.05
SourceHeadline
finance.yahoo.com logoHere's Why We're Not Too Worried About Compass Therapeutics' (NASDAQ:CMPX) Cash Burn Situation
finance.yahoo.com - August 24 at 9:05 AM
msn.com logoHC Wainwright & Co. Reiterates Compass Therapeutics (CMPX) Buy Recommendation
msn.com - August 3 at 10:23 PM
msn.com logoCompass Therapeutics GAAP EPS of -$0.09
msn.com - August 3 at 12:21 PM
finance.yahoo.com logoCompass Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
finance.yahoo.com - August 3 at 12:21 PM
msn.com logoCompass Therapeutics added to Russell indexes
msn.com - June 22 at 6:52 PM
finance.yahoo.com logoCompass Therapeutics to be Added to the Russell 2000® and Russell 3000® Indexes
finance.yahoo.com - June 22 at 6:52 PM
finance.yahoo.com logoCompass Therapeutics to be Added to the Russell 2000® and Russell 3000® Indexes
finance.yahoo.com - June 22 at 6:52 PM
marketbeat.com logoCitigroup Inc. Boosts Position in Compass Therapeutics, Inc. (NASDAQ:CMPX)
marketbeat.com - June 4 at 4:49 AM
finance.yahoo.com logoCompass Therapeutics to Participate in Upcoming Investor Events
finance.yahoo.com - June 1 at 2:33 PM
marketbeat.com logoCompass Therapeutics, Inc. (NASDAQ:CMPX) Receives Consensus Rating of "Buy" from Brokerages
marketbeat.com - May 31 at 3:34 AM
markets.businessinsider.com logoSVB Securities Keeps Their Buy Rating on Compass Therapeutics (CMPX)
markets.businessinsider.com - May 10 at 12:32 AM
marketbeat.com logoCompass Therapeutics, Inc. (NASDAQ:CMPX) Forecasted to Post FY2027 Earnings of $1.94 Per Share
marketbeat.com - May 8 at 4:50 AM
msn.com logoCompass Therapeutics: Q1 Earnings Insights
msn.com - May 4 at 1:48 PM
finance.yahoo.com logoCompass Therapeutics Reports First Quarter Financial Results and Provides Corporate Update
finance.yahoo.com - May 4 at 8:48 AM
finance.yahoo.com logoCompass Therapeutics to Participate in the H.C. Wainwright BioConnect Investor Conference at NASDAQ
finance.yahoo.com - April 26 at 9:37 AM
usnews.com logoFrequently Asked Questions: U.S. News College Compass
usnews.com - April 25 at 9:41 AM
finance.yahoo.com logoCompass Therapeutics to Participate in the Stifel 2023 Virtual Targeted Oncology Days
finance.yahoo.com - April 19 at 8:55 AM
finance.yahoo.com logoWith 55% ownership of the shares, Compass Therapeutics, Inc. (NASDAQ:CMPX) is heavily dominated by institutional owners
finance.yahoo.com - April 13 at 8:06 AM
marketbeat.com logoCompass Therapeutics, Inc. (NASDAQ:CMPX) Receives Average Recommendation of "Buy" from Analysts
marketbeat.com - April 11 at 4:19 AM
marketbeat.com logoShort Interest in Compass Therapeutics, Inc. (NASDAQ:CMPX) Rises By 17.7%
marketbeat.com - March 31 at 8:15 AM
finance.yahoo.com logoCompass Therapeutics to Participate in the Cantor Fitzgerald Future of Oncology Symposium
finance.yahoo.com - March 28 at 8:43 AM
seekingalpha.com logoCompass Therapeutics GAAP EPS of -$0.10
seekingalpha.com - March 17 at 1:01 PM
finance.yahoo.com logoWe're Hopeful That Compass Therapeutics (NASDAQ:CMPX) Will Use Its Cash Wisely
finance.yahoo.com - March 17 at 8:01 AM
marketbeat.com logoCompass Therapeutics, Inc. Forecasted to Earn Q1 2023 Earnings of ($0.11) Per Share (NASDAQ:CMPX)
marketbeat.com - March 17 at 6:20 AM
marketbeat.com logoCompass Therapeutics, Inc. (NASDAQ:CMPX) Given Average Recommendation of "Buy" by Analysts
marketbeat.com - March 17 at 3:07 AM
finance.yahoo.com logoCompass Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
finance.yahoo.com - March 15 at 9:41 AM
marketbeat.com logoCompass Therapeutics, Inc. (NASDAQ:CMPX) CEO Thomas J. Schuetz Acquires 10,000 Shares
marketbeat.com - March 10 at 4:53 PM
marketbeat.com logo1,100,399 Shares in Compass Therapeutics, Inc. (NASDAQ:CMPX) Purchased by Eventide Asset Management LLC
marketbeat.com - March 3 at 11:03 AM
seekingalpha.com logoCMPX Compass Therapeutics, Inc.
seekingalpha.com - February 15 at 11:20 PM
finance.yahoo.com logoCompass Therapeutics to Participate in the SVB Securities Global Biopharma Conference
finance.yahoo.com - February 2 at 12:50 PM
msn.com logoBenzinga's Top Ratings Upgrades, Downgrades For January 27, 2023
msn.com - January 27 at 1:10 PM
markets.businessinsider.com logoExpert Ratings for Compass Therapeutics
markets.businessinsider.com - January 27 at 1:10 PM
yahoo.com logoCo-Founder Thomas Schuetz Just Bought A Handful Of Shares In Compass Therapeutics, Inc. (NASDAQ:CMPX)
yahoo.com - January 26 at 10:13 AM
msn.com logoCompass Therapeutics added to Wedbush Best Ideas List on lead cancer candidate
msn.com - January 24 at 3:17 PM
marketbeat.com logoAnalysts Set Expectations for Compass Therapeutics, Inc.'s FY2027 Earnings (NASDAQ:CMPX)
marketbeat.com - January 20 at 9:46 AM
finance.yahoo.com logoCompass Therapeutics Announces that the Phase 2 Data of CTX-009 in Combination with Paclitaxel in Patients with Biliary Tract Cancers (BTC) will be Presented at the ASCO GI Cancers Symposium on January 20, 2023
finance.yahoo.com - January 19 at 10:16 PM
marketbeat.com logoCompass Therapeutics, Inc. (NASDAQ:CMPX) Sees Large Increase in Short Interest
marketbeat.com - January 18 at 4:10 AM
finance.yahoo.com logoCompass Therapeutics Announces First Patient Dosed in the Phase 2 U.S. Study of CTX-009 in Patients with Metastatic Colorectal Cancer
finance.yahoo.com - January 6 at 8:55 AM
finance.yahoo.com logoCompass Therapeutics Announces Presentation of Updated Results from the Ongoing Phase 2 study of CTX-009 in Biliary Tract Cancer (BTC) at the 2023 ASCO GI Cancers Symposium January 19-21
finance.yahoo.com - December 15 at 12:35 PM
marketbeat.com logoShort Interest in Compass Therapeutics, Inc. (NASDAQ:CMPX) Declines By 17.1%
marketbeat.com - December 4 at 9:07 PM
finance.yahoo.com logoCompass Therapeutics Announces First Patient Dosed in the Phase 1b CTX-471 Combination Trial with KEYTRUDA® (pembrolizumab)
finance.yahoo.com - December 1 at 6:51 PM
marketbeat.com logoCompass Therapeutics (NASDAQ:CMPX) Stock Price Down 9.2% After Insider Selling
marketbeat.com - November 30 at 1:16 AM
marketbeat.com logoCompass Therapeutics, Inc. (NASDAQ:CMPX) Receives Average Rating of "Buy" from Analysts
marketbeat.com - November 28 at 3:12 AM
finance.yahoo.com logoOne Compass Therapeutics, Inc. (NASDAQ:CMPX) insider upped their stake by 0.6% in the previous year
finance.yahoo.com - November 27 at 8:42 AM
marketbeat.com logoVered Bisker-Leib Sells 14,929 Shares of Compass Therapeutics, Inc. (NASDAQ:CMPX) Stock
marketbeat.com - November 25 at 6:37 PM
finance.yahoo.com logoCompass Therapeutics to Present at the Piper Sandler 34th Annual Healthcare Conference
finance.yahoo.com - November 22 at 7:32 PM
marketbeat.com logoCompass Therapeutics (NASDAQ:CMPX) PT Raised to $9.00 at LADENBURG THALM/SH SH
marketbeat.com - November 16 at 5:18 PM
marketbeat.com logoFY2022 Earnings Forecast for Compass Therapeutics, Inc. Issued By HC Wainwright (NASDAQ:CMPX)
marketbeat.com - November 14 at 2:29 AM
marketbeat.com logoCompass Therapeutics, Inc. (NASDAQ:CMPX) Short Interest Down 21.9% in October
marketbeat.com - November 13 at 4:43 PM
finance.yahoo.com logoCompass Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update
finance.yahoo.com - November 9 at 9:08 AM
Get Compass Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CMPX and its competitors with MarketBeat's FREE daily newsletter.



CMPX Media Mentions By Week

CMPX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CMPX
News Sentiment

0.00

0.52

Average
Medical
News Sentiment

CMPX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CMPX Articles
This Week

0

1

CMPX Articles
Average Week

Get Compass Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CMPX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:CMPX) was last updated on 9/24/2023 by MarketBeat.com Staff

My Account -